Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-03-25

Clinical Trial Update: Chlorthalidone Compared to Hydrochlorothiazide on Endothelial Function [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing chlorthalidone versus hydrochlorothiazide for endothelial function in hypertension has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chlorthalidone (chlorthalidone)
  • HYDROCHLOROTHIAZIDE (hydrochlorothiazide)

Snippet

Sponsor: Creighton University | Conditions: Hypertension | Phase 4 | Status: WITHDRAWN